LPP Monoclonal Antibody BT-MCA0848
Specifications
| 50ul / 100ul |
Background:
This gene encodes a member of a subfamily of LIM domain proteins that are characterized by an N-terminal proline-rich region and three C-terminal LIM domains. The encoded protein localizes to the cell periphery in focal adhesions and may be involved in cell-cell adhesion and cell motility. This protein also shuttles through the nucleus and may function as a transcriptional co-activator. This gene is located at the junction of certain disease-related chromosomal translocations, which result in the expression of chimeric proteins that may promote tumor growth. Alternative splicing results in multiple transcript variants.
Classification:
Primary antibody
Alternative names:
LPP; Lipoma-preferred partner; LIM domain-containing preferred translocation partner in lipoma
Species reactivity:
Human,Mouse,Monkey,Hamster
Host:
Mouse
Isotype:
IgG
Immunogen:
Purified recombinant fragment of human LPP expressed in E. Coli.
Concentration:
1 mg/ml
Molecular weight:
N/A
Applications:
WB, IHC-p, IF, ICC, ELISA
Storage:
-20°C for one year
More info:
Email: info@sobekbio.com
Orders:
Email: orders@sobekbio.com
Fine Biotech is an ISO9001:2008 Certified Company,offers a full line of quality research kits,which include ELISA Kits,related ELISA assistant reagents and more high quality antibodies, recombinant proteins. Fine Biotech technical support are delicated to providing with professional and friendly assistance for our customers. Strict and multiple quality control ensure that our products continue to successfully supply for the international market. Moreover, we strive to continuously improve the customer experience through comprehensive technical support. High quality,rapid turnaround and personal support for all FineTest services are guaranteed. Should you have any problems,or any ideas on ways that we can improve our service,please feel free to call upon us.Thank you for your interest in FineTest products and we look forward to supplying you in the near future.